NCT02513784View on ClinicalTrials.gov

Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Esophageal AdenocarcinomaBarrett's EsophagusReflux Esophagitis
Interventions
DRUG

Chlorhexidine gluconate

Chlorhexidine gluconate is a germicidal mouthwash that reduces bacteria in the mouth.

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT02513784 - Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome | Biotech Hunter | Biotech Hunter